NLRP12.com's blog with news, updates and comments on all things rare and autoinflammatory

Home
To NLRP12.com web site

To NLRP12.com web site

Click here to go back to the website at http://www.nlrp12.com

Search for:

Navigation

Home
To NLRP12.com web site
FCAS2
NLRP12
Ultra Rare
Autoinflammatory
Drugs
- Orphan Drugs
Pharma
Genetics
Autoimmune
Software
Rare Disease
Ultra Rare
UK
USA
Campaigning
Uncategorized

What advice would you give to others?

Humane Resources: Funding Restrictions in Rare Rheumatic Diseases
Rare Disease Clinical Development: The Crucial Need for Patient and Parent Involvement
Living with a rare disease: a husband and father’s perspective
Global Genes® to Convene RARE Partnering and Investor Forum to Accelerate Drug Development for Rare Diseases
Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.
We must act as England falls behind on access to rare disease medicines
App-based tool for clinicians using facial recognition, AI and genetic big data to improve rare disease diagnosis and treatment
Three new medicines cleared for use by NHS Scotland
NORD Launches Free CME Program to Educate Medical Professionals about Rare Diseases
A Nuanced Message: Marketing to the Rare Diseases Community

Advocacy Australian Autoimmune Autoinflammatory Campaigning Child Drug Costs England Genetics Hereditory Immune System India LHON Lifestyle Marketing NHS Scotland Pharma Rare Disease Rare Disease Marketing Rare Disease Registry SLE SMC UK ultra-rare USA

No comments found

Archives

Archives

| Privacy Policy | Terms & Conditions |
| Cookie Policy | Disclaimer |

Nothing on this blog is medical advice. This blog is for INFORMATION only.

If you need medical advice, please call a medical professional.

Copyright © 2024 | WordPress Theme by MH Themes